Diabetes

By Jonah Comstock February 8, 2016
A small study published in Diabetes Care, the journal of the American Diabetes Association, shows that personalized text messages with positive and negative feedback are more effective than texts that are simply reminders. The study was conducted by researchers at the Israeli Institute of Technology and one researcher was affiliated with Microsoft Research. They split 27 patients into a seven-...
By Jonah Comstock February 4, 2016
Germantown, Maryland-based Senseonics' Eversense continuous glucose monitor, which promises to be less invasive and longer lasting than traditional CGMs, still isn’t FDA cleared or CE-marked. But the company, which filed for an IPO last month, is pushing ahead on a partnership to maximize the user experience of its device, and to establish a pipeline for sending its data to users’ healthcare...
By Jonah Comstock January 21, 2016
The diabetes management space has long held a commanding lead as the most popular target for mobile health developers, according to a new blog post from Research2Guidance based on their mHealth App Developer Economics report, for which the research firm surveyed 5,000 developers. "In each survey we have conducted since 2010, diabetes has consistently been considered the therapy field offering the...
By Jonah Comstock January 14, 2016
Senseonics, a Germantown, Maryland-based company working on a longterm implantable continuous glucose monitor, has filed to go public with an IPO that, for now at least, is valued at $51.75 million.  Senseonics singular offering is a pill-sized sensor that is entirely implanted in the user’s upper arm so that it can continuously monitor their glucose levels. The device is meant to last at least...
By Jonah Comstock December 14, 2015
Samsung and Medtronic are once again teaming up, this time to build mobile tools for patients using neuromodulation therapy, a treatment used in a number of chronic conditions including chronic pain, movement disorders, and incontinence. The two companies partnered in June on diabetes around the same time Medtronic received FDA clearance for its MiniMed Connect device that connects Medtronic CGMs...
By Jonah Comstock November 11, 2015
When Kenneth Stack's son was diagnosed with Type 1 diabetes just before his fifth birthday, the doctor told Stack he was just a few years too early for a major medical breakthrough. "I remember, trying to make sense of all of this, the doctor saying 'In three years, we’ll have perfected the artificial pancreas and you won’t have to worry about this'," Stack recalled at a panel discussion at the...
By Jonah Comstock September 30, 2015
Voluntis's Diabeo app, not available in the United States French medical app company Voluntis is partnering with Roche Pharma France, a subsidiary of Roche, to develop a mobile-based therapy for breast cancer. Voluntis makes companion apps as medical devices. It has so far focused on the areas of diabetes, hemophilia, and coagulation. Voluntis actually worked with Roche Diagnostics in the past...
By Jonah Comstock September 23, 2015
Glooko and Joslin's HypoMap Joslin Diabetes Center is running a small trial to pilot test a mobile health app and an online nutrition education platform for people with Type 1 diabetes, according to a ClinicalTrials.gov posting. The web platform will help educate patients about how to optimize their glucose and analyze their after-meal behavior. The app will facilitate data logging to help...
By Jonah Comstock September 16, 2015
An Oscar-branded Misfit Flash device. Oscar, a small New York City-based health insurer noted for its individual focus and digital health savvy, has secured a $32.5 million investment from Google Capital, one of the search giant's two investment arms. The investment may well be strategic, according to the Wall Street Journal, which broke the story. Last April, Oscar raised $145 million in a...
By Jonah Comstock September 8, 2015
Google and Novartis are working on two smart contact lenses, and news broke this week about both of them: A new patent application sheds light on how Google might power its glucose-sensing contact lens, just a week after partner Novartis told a Swiss newspaper it was on track for human trials in 2016 of an autofocus lens for presbyopia patients. Patent applications don't always presage exactly...

Editor's Pick